Trial Profile
A single-blind prospective study of quetiapine for the treatment of mood disorders in adolescents
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Mood disorders
- Focus Therapeutic Use
- 17 Jul 2012 Actual end date (1 Apr 2006) added as reported by ClinicalTrials.gov.
- 17 Jul 2012 Actual initiation date (1 Jun 2003) added as reported by ClinicalTrials.gov.
- 25 Aug 2006 New trial record.